Autopsy report · NCT00445705

Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome

“This study was terminated early due to company decision. Part B was never conducted.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 10 months before it stopped.
• 211 participants enrolled.
• Results were posted on the registry 4 years after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Allergan

Sponsor type

Industry

Conditions

Fibromyalgia

Interventions

placebo; AGN 203818; AGN 203818; AGN 203818

Participants

211

Sites

3

Countries

Switzerland, United Kingdom, United States

Trials that died the same way

• Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
  “Study was never initiated due to company decision. No study subjects were ever enrolled or treated.” (81% match in meaning)
• Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne
  “Study was never initiated due to company decision. No study subjects were ever enrolled or dosed.” (80% match in meaning)
• Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
  “This study was terminated early due to company decision.” (80% match in meaning)
• PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer
  “The study was terminated early due to company decision.” (79% match in meaning)
• Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients
  “Study was terminated early for strategic reasons. Only Part I of the study was completed.” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.